EGM
LRMR icon

Engineers Gate Manager’s Larimar Therapeutics LRMR Stock Holding History

Engineers Gate Manager’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.8K Buy
+22,557
New +$89.6K ﹤0.01% 2109
2025
Q1 		– Sell
-11,270
Closed -$43.6K – 2393
2024
Q4 		$43.6K Buy
+11,270
New +$74.4K ﹤0.01% 2105
2024
Q3 		– Sell
-11,280
Closed -$81.8K – 2268
2024
Q2 		$81.8K Sell
11,280
-1,500
-12% -$11.5K ﹤0.01% 1768
2024
Q1 		$97K Buy
+12,780
New +$99.6K ﹤0.01% 1751
2023
Q2 		– Sell
-10,175
Closed -$46.1K – 1901
2023
Q1 		$46.1K Buy
+10,175
New +$53.2K ﹤0.01% 1561

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Engineers Gate Manager's LRMR Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 22,557 shares worth $68.8K. The stake represents ﹤0.01% of the portfolio and ranks #2109 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in LRMR as recently as Q4 2024.

Engineers Gate Manager first reported a position in LRMR in Q1 2023 and has held it in 5 quarters since. The position peaked at $97K in Q1 2024. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Engineers Gate Manager held 22,557 shares of Larimar Therapeutics worth $68.8K as of Q2 2026.
  • Larimar Therapeutics was a new Engineers Gate Manager position in Q2 2026.
  • Larimar Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2109 holding.
  • Engineers Gate Manager first reported a position in Larimar Therapeutics in Q1 2023 and has held it in 5 quarters since.
  • Engineers Gate Manager's Larimar Therapeutics position peaked at $97K in Q1 2024.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.